about
Inflammation as a Driver of Clonal Evolution in Myeloproliferative NeoplasmAlzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brainThe ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Molecular mimicry in Helicobacter pylori infections.Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytesCaspase-1: an integral regulator of innate immunity.Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation[Caspase-1 regulates autoinflammation in rheumatic diseases].IL-1β and IL-18: inflammatory markers or mediators of hypertension?Geometrical Frustration in Interleukin-33 Decouples the Dynamics of the Functional Element from the Folding Transition State EnsembleIL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistanceIL-33 Signaling Protects from Murine Oxazolone Colitis by Supporting Intestinal Epithelial Function.Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.Role of the IL-33-ST2 axis in sepsis.Prolonged activation of IL-5-producing ILC2 causes pulmonary arterial hypertrophyThe potential role of IL-33/ST2 signaling in fibrotic diseases.Transcriptional profiling of human gingival fibroblasts in response to multi-species in vitro subgingival biofilms.Role of the Immune System in Hypertension.Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation.
P2860
Q26779936-7807560C-3352-49C6-A892-ECE6B6DFB3B4Q33589491-7E0F7CC2-165B-4328-A329-955E11C54F1CQ33593742-03D2C49D-C275-44D9-8F58-1D91881F4E02Q33805866-5D14B630-D60C-4840-84A9-E7E96BBA497CQ33911558-433AD213-5B4C-47A9-8094-B1AD6F490EA9Q34044187-045C065F-4B40-4A9F-8EC0-7AB08A16DFCFQ34429568-591D975D-B34A-4A78-B4D4-EAE944D18F83Q34520488-91A3B81E-924A-44E0-9F45-6E05242D191FQ34914125-CCBC622E-D6B7-41D9-9238-D3769823D3D9Q35858724-A025AE93-CFD1-4681-A9F6-E5FF9673D514Q36005876-32534FA2-525B-4AFB-913F-5FCC663ABFC3Q36303477-6A3D10AF-EC7D-486F-9447-5EEFCE6A0595Q36744984-1277267F-42A5-48E0-B326-E7B8B0411386Q37126011-F1BAB512-F408-41CE-BF0A-FC54A0FC35F0Q37620811-E2362410-67AA-43A9-A71B-9A0C3B1121BEQ37730806-79D8FC04-51AB-430D-9FFB-E5BC96D6BE40Q38424483-8CF815BA-C431-415C-A56B-E5A8C62EB913Q38477460-50EEF987-7C69-4958-8151-600BD8B93C4BQ39342382-ACA76F89-7014-48E6-B850-DBE0C089498DQ40470696-584435EE-27FE-478A-AD90-39E0EFF19FD3Q47414882-B124F1FE-BD76-48CF-B9C5-C2B21B31A97D
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging role of interleukin-33 in autoimmune diseases.
@en
type
label
Emerging role of interleukin-33 in autoimmune diseases.
@en
prefLabel
Emerging role of interleukin-33 in autoimmune diseases.
@en
P2093
P2860
P356
P1433
P1476
Emerging role of interleukin-33 in autoimmune diseases.
@en
P2093
Debbie Allan
Hui-Rong Jiang
Karen J Fairlie-Clarke
P2860
P356
10.1111/IMM.12174
P50
P577
2014-01-01T00:00:00Z